THE PREDISPOSITION FOR TYPE 2 DIABETES MELLITUS AND METABOLIC SYNDROME
Zenoaga-Barbăroșie C, Berca L, Vassu-Dimov T, Toma M, Nica MI, Alexiu-Toma OA, Ciornei C, Albu A, Nica S, Nistor C, Nica R
*Corresponding Author: Corresponding Author: Ass. Prof. Silvia Nica MD, PhD, Bucharest Emergency University Hospital, Splaiul Independentei Street, no 169, 5 District, Bucharest, Romania, 050098 Tel.: +40-21-31880500, email: silvia.nica@umfcd.ro
page: 21

RESULTS

The clinical data of subjects enrolled in the study are shown in Table 1. MetS patients have 3 (64%), 4 (32%) or 5 (4%) NCEP ATP III criteria for diagnosis. We found that T2DM was diagnosed at an earlier age compared to MetS (p=0.0003). The statistical significance of difference was greater when comparing patients who are carriers of OXTR G (54.04 vs 56.05 years old, p=0.0002) or both OXTR G and eNOS b alleles (54.00 vs 56.05, p=0.00016). Our results showed that the SOD1 AA genotype (p=0.0006) and the presence of both ACE I and OXTR A alleles (p=0.0005) are protective factors for T2DM. T2DM patients with lower triglyceride levels (<150 mg/dl) were more frequent carriers of SOD1 AA and AC genotypes when compared to HC subjects (p=0.0002 and p=0.0005, respectively). Similarly, SOD1 AA and AC genotypes were more frequent in T2DM patients with HDL levels over 40 mg/dl when comparing to HC (p=0.0002 and p=0.0004, respectively). Hypertensive T2DM patients were more frequent carriers of ACE DD genotype than HC (56.76% vs 25.83%, p=0.0005) (Table 3). In addition, this genotype, in association with eNOS bb or OXTR G, was found more frequently in alcohol consumers compared to those without this habit (p<0.0001) (Table 3). No other statistically significant associations were found between the investigated groups or subgroups of subjects.



Number 27
VOL. 27 (2), 2024
Number 27
VOL. 27 (1), 2024
Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006